Leading medical organizations team up to bring new TB treatments to those in need
03/19/2015. International organizations Partners In Health (PIH), Médecins Sans Frontières (MSF), Interactive Research and Development (IRD) and their financial partner UNITAID will start in April the endTB project, a partnership aimed at radically changing the management of multidrug-resistant tuberculosis (MDR-TB).
By 2019, endTB will provide access to two new anti-TB drugs (bedaquiline and delamanid), for 2,600 MDR-TB patients in 16 countries. These are the first new anti-TB drugs developed in over 50 years and these drugs offer new hope to patients suffering from MDR-TB.
Read the article on MSF website
Related Articles
A Study on the Roots of Restraint in War
03/15/2017. A two-year research initiative launched by the ICRC to advance to understand how norms of restraint develop and spread through State armed forces and non-State armed groups.
EU-Turkey Agreement: the concern of the “Œuvre d’Orient”
03/19/2016. Mgr Pascal Gollnisch, director of the the Œuvre d’Orient expressed his reluctance.
Speech by Angelina Jolie ‘In defense of internationalism’
03/15/2017. Delivered at the Sergio Vieira de Mello Annual Lecture, in Geneva, Switzerland
